Oncology trials are among the most complex and time-sensitive in clinical research, making efficient start-up critical to patient impact and program success. This session explores proven strategies and real-world innovations for accelerating trial activation in oncology—from protocol finalization to first patient dosed. Attendees will learn how to navigate regulatory requirements, streamline site selection and contracting, and align cross-functional teams to reduce delays without compromising quality or compliance.

Learning Objectives:

1. Identify common bottlenecks in oncology trial start-up and strategies to overcome them.
2. Apply process improvements and technology solutions to accelerate site activation and patient enrollment.
3. Develop collaborative approaches to align sponsors, CROs, and sites for faster trial launch in oncology.